Indicatrix (ICX; www.Indicatrix.co.uk) is a newly formed Contract Research Organisation that has spun out of Newcastle University’s chemistry department. ICX was founded in 2019 by Dr Michael Hall and Dr Michael Probert following the discovery and subsequent publication of their highly acclaimed invention: Encapsulated Nanodroplet Crystallisation (ENaCt) – a novel technique which allows crystallisation experiments to be preformed at scales previously unthinkable.
Using ENaCt technology, ICX undertakes contract research for leading pharmaceutical and agrochemical companies helping them to access previously inaccessible crystalline forms of bioactive molecules (e.g. new drugs) in combination with structural analysis via single crystal X-ray diffraction.
1 job with ICX
The student would be one of the first in the world to be trained to use ENaCt as well as the associated analytical techniques.